Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Clinical trial NCT05555589 · RECRUITING
Trial details
- NCT number
- NCT05555589
- Sponsor
- ReGenTree, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-11
- Primary completion
- 2026-04-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.